Aspirin Versus Low-Molecular-Weight Heparin After Total Hip Arthroplasty

被引:0
|
作者
Granziera, Serena [1 ]
Cohen, Alexander T. [2 ]
机构
[1] Univ Padua, Padua, Italy
[2] Kings Coll Hosp London, London, England
关键词
PROPHYLAXIS; TRIAL;
D O I
10.7326/00030003-4819-159-7-201310010-00017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:502 / 502
页数:1
相关论文
共 50 条
  • [1] Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty A Randomized Trial
    Anderson, David R.
    Dunbar, Michael J.
    Bohm, Eric R.
    Belzile, Etienne
    Kahn, Susan R.
    Zukor, David
    Fisher, William
    Gofton, Wade
    Gross, Peter
    Pelet, Stephane
    Crowther, Mark
    MacDonald, Steven
    Kim, Paul
    Pleasance, Susan
    Davis, Nicki
    Andreou, Pantelis
    Wells, Philip
    Kovacs, Michael
    Rodger, Marc A.
    Ramsay, Tim
    Carrier, Marc
    Vendittoli, Pascal-Andre
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (11) : 800 - +
  • [2] Intrahepatic hemorrhage after use of low-molecular-weight heparin for total hip arthroplasty
    Houde, JP
    Steinberg, G
    JOURNAL OF ARTHROPLASTY, 1999, 14 (03): : 372 - 374
  • [3] The Cost Analysis Of Aspirin Versus Low Molecular Weight Heparin For Thromboprophylaxis Following Total Hip Arthroplasty
    Chauhan, Owen
    Skedgel, Chris
    Pleasance, Susan
    Thompson, Kara
    Anderson, David
    BLOOD, 2013, 122 (21)
  • [4] Dosing and timing of low-molecular-weight heparin thromboprophylaxis in total hip arthroplasty
    Colwell, CW
    ORTHOPEDICS, 2003, 26 (11) : 1155 - 1161
  • [5] Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty
    Edwards, John Z.
    Pulido, Pamela A.
    Ezzet, Kace A.
    Copp, Steven N.
    Walker, Richard H.
    Colwell, Clifford W., Jr.
    JOURNAL OF ARTHROPLASTY, 2008, 23 (08): : 1122 - 1127
  • [6] Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty
    Colwell, Clifford W., Jr.
    Hardwick, Mary E.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (452) : 181 - 185
  • [7] Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty
    Zou, Yue
    Tian, Shaoqi
    Wang, Yuanhe
    Sun, Kang
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (07) : 660 - 664
  • [8] Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty
    Rader, CP
    König, A
    Hendrich, C
    Eulert, J
    JOURNAL OF ARTHROPLASTY, 1998, 13 (02): : 180 - 185
  • [9] Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
    O'Toole, Robert V.
    Stein, Deborah M.
    O'Hara, Nathan N.
    Frey, Katherine P.
    Taylor, Tara J.
    Scharf-stein, Daniel O.
    Carlini, Anthony R.
    Sudini, Kuladeep
    Degani, Yasmin
    Slobogean, Gerard P.
    Haut, Elliott R.
    Obremskey, Wil-liam
    Firoozabadi, Reza
    Bosse, Michael J.
    Goldhaber, Samuel Z.
    Marvel, Debra
    Castillo, Renan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (03): : 203 - 213
  • [10] LOW-MOLECULAR-WEIGHT HEPARIN VERSUS ASPIRIN AND DIPYRIDAMOLE AFTER FEMOROPOPLITEAL BYPASS-GRAFTING
    EDMONDSON, RA
    COHEN, AT
    DAS, SK
    WAGNER, MB
    KAKKAR, VV
    LANCET, 1994, 344 (8927): : 914 - 918